Logo image of CTB

Cooper Tire & Rubber Company (CTB) Stock Fundamental Analysis

NYSE:CTB - New York Stock Exchange, Inc. -

60.17  -0.03 (-0.05%)

After market: 60.17 0 (0%)

Fundamental Rating

3

Overall CTB gets a fundamental rating of 3 out of 10. We evaluated CTB against 83 industry peers in the Automobile Components industry. CTB has a bad profitability rating. Also its financial health evaluation is rather negative. CTB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CTB was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 5.97%
ROE 12.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 10.39%
PM (TTM) 6.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

CTB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CTB has an Altman-Z score of 3.94. This indicates that CTB is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.22 indicates that CTB is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 3.94
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CTB has a Current Ratio of 2.44. This indicates that CTB is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.72 indicates that CTB should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.72

More info and screens

5

3. Growth

3.1 Past

CTB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 124.52%, which is quite impressive.
Measured over the past years, CTB shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.24% on average per year.
CTB shows a decrease in Revenue. In the last year, the revenue decreased by -0.75%.
CTB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.24% yearly.
EPS 1Y (TTM)124.52%
EPS 3Y-3.11%
EPS 5Y-5.24%
EPS Q2Q%286.96%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-4.06%
Revenue growth 5Y-3.24%
Sales Q2Q%23.35%

3.2 Future

The Earnings Per Share is expected to grow by 31.46% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.63% on average over the next years. This is quite good.
EPS Next Y52.22%
EPS Next 2Y33.82%
EPS Next 3Y32.03%
EPS Next 5Y31.46%
Revenue Next Year18.85%
Revenue Next 2Y11.95%
Revenue Next 3Y11.46%
Revenue Next 5Y11.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTB Yearly Revenue VS EstimatesCTB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
CTB Yearly EPS VS EstimatesCTB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.29, the valuation of CTB can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, CTB is valued a bit cheaper.
CTB is valuated reasonably with a Price/Forward Earnings ratio of 11.91.
The average S&P500 Price/Forward Earnings ratio is at 22.70. CTB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.29
Fwd PE 11.91
CTB Price Earnings VS Forward Price EarningsCTB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.14
CTB Per share dataCTB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTB's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y33.82%
EPS Next 3Y32.03%

More info and screens

2

5. Dividend

5.1 Amount

CTB has a yearly dividend return of 0.70%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.27, CTB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

CTB has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0%
Div Incr YearsN/A
Div Non Decr YearsN/A
CTB Yearly Dividends per shareCTB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2Y33.82%
EPS Next 3Y32.03%

More info and screens

Cooper Tire & Rubber Company

NYSE:CTB (6/4/2021, 8:04:01 PM)

After market: 60.17 0 (0%)

60.17

-0.03 (-0.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner Change0%
Market Cap3.04B
Analysts60
Price Target53.04 (-11.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend0.42
Dividend Growth(5Y)0%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 11.91
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB N/A
EV/EBITDA 6.14
EPS(TTM)3.48
EY5.78%
EPS(NY)5.05
Fwd EY8.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS52.36
BVpS28.16
TBVpSN/A
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.97%
ROE 12.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 10.39%
PM (TTM) 6.67%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.72
Altman-Z 3.94
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.52%
EPS 3Y-3.11%
EPS 5Y-5.24%
EPS Q2Q%286.96%
EPS Next Y52.22%
EPS Next 2Y33.82%
EPS Next 3Y32.03%
EPS Next 5Y31.46%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-4.06%
Revenue growth 5Y-3.24%
Sales Q2Q%23.35%
Revenue Next Year18.85%
Revenue Next 2Y11.95%
Revenue Next 3Y11.46%
Revenue Next 5Y11.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A